Skip to main content
Log in

Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to compare the safety and short-term efficacy of transcatheter arterial chemoembolization (TACE) using cisplatin-Lipiodol suspension (CP/Lp) with that using epirubicin-Lipiodol emulsion (EP/Lp) in patients with recurrent hepatocellular carcinoma (HCC).

Materials and methods

A total of 28 HCC patients were enrolled prospectively and assigned to the CP/Lp group or EP/Lp group. Adverse effects related to TACE were graded; and the treatment effect (TE) on HCC nodules at 3 months and overall tumor response at 6 months were assessed as the endpoint.

Results

No significant difference was observed between the groups regarding the frequency of adverse effects of grade 3 or less. The TE rates for 100% necrosis plus >50% necrosis in 62 HCC nodules in the CP/Lp group and 75 HCC nodules in the EP/Lp group were 72.6% and 66.7%, respectively (P = 0.894). Overall tumor response revealed that six patients (50.0%) in the CP/Lp group and six patients (37.5%) in the EP/Lp group had a partial response plus a complete response, with no significant difference (P = 0.615). TACE-free control curves for both groups revealed no significant difference (P = 0.513).

Conclusion

No significant difference was found with regard to adverse effects, the treatment effect on HCC nodules, or overall tumor response between the CP/Lp and EP/Lp groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002;359:1734–1739.

    Article  PubMed  Google Scholar 

  2. Liang TJ, Jeffers IJ, Reddy KR, Medina M, Parkeret IT, Cheinquer H, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993;18:1326–1333.

    CAS  PubMed  Google Scholar 

  3. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463–472.

    Article  CAS  PubMed  Google Scholar 

  4. Yamada R, Sato M, Kawabata M, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397–401.

    CAS  PubMed  Google Scholar 

  5. Nishimine K, Uchida H, Matsuo N, Sakaguchi H, Hirohashi S, Nishimura Y, et al. Segmental transarterial chemoembolisation with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma; follow-up CT and therapeutic results. Cancer Chemother Pharmacol 1994;33:60–68.

    Article  Google Scholar 

  6. Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, et al. Prospective and randomized trial of Lipiodol-transcatheter arterial chemoembolisation for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study)—The Cooperative Study Group for Liver Cancer Treatment of Japan. Semin Oncol 1997;24(S6):38–45.

    Google Scholar 

  7. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, et al. Transcatheter oily embolisation for hepatocellular carcinoma: a 4-year study of 127 French patients. Cancer 1994;74:16–24.

    Article  CAS  PubMed  Google Scholar 

  8. Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987;60:1194–1203.

    Article  CAS  PubMed  Google Scholar 

  9. Takayasu K, Muramatsu Y, Maeda T, Iwata R, Fukuoka H, Moriyama N, et al. Targeted transarterial oily chemoembolisation for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 2001;176:681–688.

    CAS  PubMed  Google Scholar 

  10. Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989;97:965–971.

    CAS  PubMed  Google Scholar 

  11. Konno T, Maeda H, Iwai K, Tashiro S, Maki S, Morinaga T, et al. Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol 1983;19:1053–1065.

    Article  CAS  PubMed  Google Scholar 

  12. Ono Y, Yoshimasu T, Ashikaga R, Inoue M, Shindou H, Fuji K, et al. Long-term results of Lipiodol-transcatheter arterial chemoembolisation with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol 2000;23:564–568.

    Article  CAS  PubMed  Google Scholar 

  13. Sato M, Yamada R, Uchida B, Hedgepeth P, Rosch J. Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver. Cardiovasc Intervent Radiol 1993;16:348–354.

    Article  CAS  PubMed  Google Scholar 

  14. Sahara S, Tanihata H, Sato M, Kawai N, Takasaka I, Minamiguchi H, et al. Effects of hepatic artery chemoembolization using cisplatin-Lipiodol suspension with gelatin sponge particles on swine liver. J Vasc Interv Radiol 2009;20:1359–1364.

    Article  PubMed  Google Scholar 

  15. Cooley ME, Davis L, Abrahm J. Cisplatin: a clinical review. Part II. Nursing assessment and management of side effects of cisplatin. Cancer Nurs 1994;17:283–293.

    CAS  PubMed  Google Scholar 

  16. Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, et al. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for heaptocellular carcinoma. Hepatogastroenterology 2003;50:809–813.

    CAS  PubMed  Google Scholar 

  17. Uyama N, Hatano N, Maetani Y, Isoda H, Shibata T, Taura K, et al. Efficacy and toxicity of transcatheter arterial chemoembolisation with cisplatin suspended in Lipiodol for unresectable hepatocellular carcinoma. Jpn J Cancer Chemother 2008;35:775–780.

    Google Scholar 

  18. Masuda M. Evaluation of basic and clinical study on effect of anticancer drugs of Lipiodol in chemoembolization on liver tissue. J Wakayama Med Soc 2002;53:185–192.

    CAS  Google Scholar 

  19. Kamada K, Nakanishi T, Kitamoto M, Aikata H, Kawakami Y, Imaoka S, et al. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin Lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol 2001;12:847–854.

    Article  CAS  PubMed  Google Scholar 

  20. Chang JM, Tzeng WS, Pan HB, Yang CF, Lai KH, et al. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma: a randomized controlled study. Cancer 1994;74:2449–2453.

    Article  CAS  PubMed  Google Scholar 

  21. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 5th edition, revised version. Tokyo: Kanehara; 2009 p. 29–34.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Morio Sato.

About this article

Cite this article

Sahara, S., Kawai, N., Sato, M. et al. Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma. Jpn J Radiol 28, 362–368 (2010). https://doi.org/10.1007/s11604-010-0436-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-010-0436-y

Key words

Navigation